Emergent BioSolutions ($EBS) Insider Trading & Smart Money Activity

Emergent BioSolutions Inc. · Latest filing Oct 7, 2026

Emergent BioSolutions Inc. ($EBS) has 2 insider trades on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($145.79K), net -$145.79K.

Insider buyers (12 mo)

0

Insider sellers (12 mo)

2

Net insider $ (12 mo)

-$145.79K

Congress trades (12 mo)

0

13F moves on file

0

Analyst ratings on file

0

EBS insider buying and selling by quarter

Quarter	Insider buys	Insider sales	Congress buys / sales	13F added / cut
Q1 2026	0	0	0 / 0	0 / 0
Q2 2026	0	0	0 / 0	0 / 0
Q3 2026	0	0	0 / 0	0 / 0
Q4 2026	0	2 · $145.79K	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All EBS insider, congress, 13F and analyst activity

All Insiders

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
Oct 7, 2026	Insider	DeGolyer Donald WDirector	Sell (Open-market sale) 10b5-1	17.80K sh	$126.20K						—
Oct 1, 2026	Insider	Williams Paul AnthonySVP, Products Business	Sell (Open-market sale) 10b5-1	3K sh	$19.59K						—

1W / 1M / 6M = how EBS moved from the trade or filing date.

Insider trading in EBS: who is buying and selling

Insider	Role	Trades	Open-market net	Shares held	Last trade
DeGolyer Donald W	Director	1	-$126.20K		Oct 7, 2026
Williams Paul Anthony	SVP, Products Business	1	-$19.59K		Oct 1, 2026

Frequently asked questions

Are EBS insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $145.79K, a net -$145.79K.

What is the latest insider trade in EBS?

DeGolyer Donald W, Director filed a sell (open-market sale) of 17.80K sh worth $126.20K on Oct 7, 2026.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.